Bayer | BAYN - Selling And Administration Expenses

Stock Price
39.70
Daily Change
-0.43 -1.06%
Monthly
3.62%
Yearly
86.67%
Q2 Forecast
38.53

Bayer reported EUR4.05B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Air Liquide EUR 2.57B 1.27B Dec/2024
Akzo Nobel EUR 811M 28M Dec/2025
Alcon AG USD 901M 36M Dec/2025
Amarin USD 18.97M 1.03M Dec/2025
Arkema EUR 213M 18M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
BASF EUR 2.21B 13M Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Beiersdorf EUR 271M 51M Dec/2025
Corteva USD 860M 135M Dec/2025
Covestro EUR 445M 8M Dec/2025
Essilor EUR 5.62B 4.53B Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
Genmab DKK 208M 60M Dec/2025
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 275.3M 9.7M Dec/2025
Henkel EUR 3.49B 38M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Johnson Matthey GBP 170M 87M Dec/2025
Linde USD 880M 40M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Nutrien USD 981M 36M Dec/2025
Philips EUR 1.31B 127M Dec/2025
PPG Industries USD 905M 71M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
SAP EUR 2.63B 78M Dec/2025
Solvay EUR 155M 40M Dec/2025
UCB EUR 1.47B 193M Dec/2025
Vinci EUR 197M 49M Jun/2025